Pamol Flash

Quick links to important sections

Pamol Flash

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pamol Flash

What is Pamol Flash? (Overview)

Pamol Flash is a specialized, fast-acting medication for the temporary relief of mild to moderate pain and fever, distinguished primarily by its unique fast-dissolving delivery system. The formulation is built around a single, highly effective, and widely studied active component.


Quick Facts About Pamol Flash

Property Description
Active Ingredient Paracetamol (Acetaminophen)
Form Fast-Dissolving Tablet (Orally Disintegrating Tablet)
Pharmacological Class Non-opioid analgesic and antipyretic
Common Purpose Relief of mild-to-moderate pain and fever reduction
Origin Synthetic chemical compound

What Type of Medicine is Pamol Flash?

Pamol Flash is classified as a non-opioid analgesic and an antipyretic medicine, containing the single active substance, paracetamol (known in many countries as acetaminophen). This choice of active ingredient is recognized for its reliable safety profile when used as directed. Paracetamol is a synthetic compound with a central pain-relieving action.

Paracetamol is distinct from nonsteroidal anti-inflammatory drugs (NSAIDs) because it provides relief primarily through central action and is generally well-tolerated by the stomach, making it a preferred Over-the-Counter (OTC) option for many individuals.

The Role of the Fast-Dissolving (Flash) Format

The "Flash" designation denotes the product's specialized orally disintegrating tablet (ODT) form. This design allows the tablet to disintegrate almost instantaneously on the tongue, often without the need for water, distinguishing it from conventional, swallowable solid forms.

This rapid-disintegration technology is engineered to facilitate a fast onset of action, which may provide more immediate relief for acute symptoms, such as a sudden tension headache. Additionally, the Flash format offers a major practical benefit by improving convenience and simplifying administration for patient groups who have difficulty swallowing traditional pills.

What is the Main Therapeutic Purpose?

The principal therapeutic goal of Pamol Flash is to provide dual symptomatic relief by achieving both pain relief (analgesia) and temperature reduction (antipyresis). It is intended for managing general, non-severe aches and discomfort associated with common conditions. Its purpose is purely palliative—to restore comfort and well-being without treating the underlying cause of the illness.

Regulatory References

  1. Acetaminophen: MedlinePlus Drug Information

What side effects are possible with Pamol Flash?

Possible Side Effects and Safety Information

The safety profile of Pamol Flash, which contains the active ingredient paracetamol (acetaminophen), is extensively documented by regulatory authorities. When used at therapeutic doses, adverse reactions are generally infrequent, with official classifications primarily focused on rare and very rare events.

Officially Documented Adverse Reactions

Adverse effects are categorized by the body system involved:

  • Hepatobiliary Disorders: Liver damage (hepatotoxicity) is the most critical safety domain. Severe liver damage and acute liver failure are documented, often associated with use exceeding the maximum recommended daily amount.
  • Skin and Immune System Disorders: These are generally classified as very rare and include hypersensitivity reactions like anaphylaxis and severe cutaneous adverse reactions (SCARs), such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).
  • Blood and Lymphatic System Disorders: Rare haematological issues, including blood dyscrasias, thrombocytopaenia, and agranulocytosis, are listed in regulatory documents.
  • Renal and Urinary Disorders: Acute tubular necrosis and papillary necrosis are documented, particularly in association with prolonged administration.

Safety Considerations for Specific Populations

Official labels define safety constraints based on a patient’s underlying health status:

  • Hepatic and Renal Impairment: Caution is necessary in individuals with pre-existing hepatic or severe renal impairment. Severe active liver disease is often a listed contraindication.
  • Risk Factors: Individuals with chronic alcoholism or conditions leading to glutathione depletion are identified as being at an increased risk of hepatic damage or high anion gap metabolic acidosis.
  • Time-Related Patterns: Regulatory safety notes indicate that prolonged regular daily use may interact with certain blood thinners and has been associated with renal issues. Additionally, an analgesic-overuse headache may develop with long-term use (more than three months).

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with products containing paracetamol, the active ingredient in Pamol Flash, is a serious medical concern that can cause severe liver damage and, if left untreated, can be fatal. This risk remains even if initial symptoms are mild or absent.

Overdose Manifestations

Symptoms of an overdose may not appear until several hours or even days after taking too much. Initial, non-specific symptoms may include nausea, vomiting, and abdominal pain.

Signs that indicate severe toxicity, requiring immediate medical attention, include:

  • Jaundice (yellowing of the skin or eyes)
  • Right upper quadrant abdominal pain (where the liver is located)
  • Confusion or severe drowsiness
  • Passing no urine at all for eight hours (sign of acute kidney injury)

Emergency Action

You must seek emergency medical advice immediately if you suspect a paracetamol overdose, even if you feel well and have no symptoms. Early treatment is critical. If treatment with the antidote, N-acetylcysteine (NAC), is started within eight hours of ingestion, it is highly effective at preventing liver damage.

Do not wait for symptoms to develop. Contact emergency services or go to the nearest emergency department right away, taking the medicine packaging with you. Treatment is based on the amount ingested and the time elapsed since ingestion.

Therapeutic Uses of Pamol Flash

The fundamental therapeutic purpose of Pamol Flash plays a role in managing symptoms by offering supportive symptomatic relief across key therapeutic domains.

Supportive Relief for Common Aches and Mild Discomfort

Pamol Flash is primarily used for managing symptoms related to physical discomfort associated with acute or episodic changes. It generally helps with symptoms such as tension headaches, acute toothaches, backache, and general aches related to muscular stiffness. This is commonly used across conditions presenting with acute episodes, where additional symptomatic support for mild-to-moderate pain is needed. It plays a role in contributing to improved day-to-day comfort during periods of heightened symptoms.

Management of Fever and Systemic Symptom Burden

The medication is relevant in contexts marked by the presence of fever (pyrexia) and associated systemic malaise, a common pattern in conditions involving episodic or fluctuating manifestations like the cold and flu. It helps address symptom clusters that may become intense or disruptive, offering supportive therapeutic benefit to ease the overall symptom load. It is also commonly used across conditions characterized by recurrent manifestations, such as post-vaccination discomfort or primary dysmenorrhea. The product format may assist with maintaining functional stability in scenarios where short-term symptomatic assistance is needed.

“It is considered relevant for temporary symptom management in scenarios where pain or fever create noticeable physiological strain.”


Quick Fact: Relief for Mild-to-Moderate Pain and Fever

Regulatory References

  1. NIH StatPearls overview of Acetaminophen

Eligibility and Restrictions for Use

Eligibility and Contraindications

The eligibility for Pamol Flash (paracetamol/acetaminophen) is strictly defined by regulatory guidelines that categorize individuals based on medical status and age. Use is absolutely contraindicated in populations with known hypersensitivity to the active ingredient or any excipients in the product. It is also strictly prohibited for patients diagnosed with severe hepatic impairment or severe active liver disease.

Conditional and Restricted Use

Caution is explicitly required for individuals with existing non-severe hepatic impairment, severe renal impairment, chronic malnutrition, or severe hypovolemia. Furthermore, regulatory agencies advise against use for individuals who regularly consume three or more alcoholic drinks daily, due to the increased risk of severe liver damage.

Age and Special Populations

The medicine is generally permitted for use in adults and older adults, with regulatory data showing no significant difference in safety or effectiveness for the geriatric population. Use in children is allowed only when strict age and weight-based limits defined by the product label are followed. Pamol Flash is generally considered compatible for short-term management during both pregnancy and breastfeeding.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information identifies specific drug and substance combinations where the potential for altered effectiveness or risk is documented.

Contraindications and Restrictions

  • Product Duplication Prohibition: Co-administration with any other product containing acetaminophen or paracetamol is a mandatory prohibition, strictly enforced to prevent accidental dose excess and the associated risk of hepatic injury.
  • Chronic Alcohol Consumption: Severe liver damage may occur if three or more alcoholic drinks are consumed daily while using this product, as cited in official warnings.

Documented Pharmacodynamic and Metabolic Interactions

Interacting Substance/Class Official Interaction Outcome
Oral Anticoagulants (e.g., Warfarin) Prolonged regular daily use may enhance the anticoagulant effect and increase the risk of bleeding. Occasional use is typically documented as having no significant effect.
Busulfan (Chemotherapeutic Agent) Increases the risk of Busulfan toxicity; avoidance or limitation is advised 72 hours before and during Busulfan treatment.
Hepatic Enzyme Inducers (e.g., Rifampicin, Carbamazepine, Phenytoin) May reduce circulating levels of the active substance or increase the hepatotoxic potential, particularly in overdose.
Flucloxacillin (Antibiotic) Associated with the risk of high anion gap metabolic acidosis in susceptible patients.

Absorption and Clearance Modifiers

  • Metoclopramide or Domperidone may increase the speed of the active substance's absorption.
  • Cholestyramine may reduce and slow the absorption, requiring separation of administration by at least one hour.
  • Probenecid may reduce clearance, leading to increased plasma concentrations.

Mechanism of Action

Central Suppression of Prostaglandin Mediators

The mechanism of Pamol Flash (Paracetamol/Acetaminophen) centers on targeted action within the Central Nervous System (CNS). The molecule functions as an inhibitor of the peroxidase site of the Cyclooxygenase (COX) enzyme system, particularly in low-peroxide environments. This molecular interaction selectively reduces the synthesis of Prostaglandin E2 (PGE2) . In the hypothalamus, this action resets the abnormally elevated thermoregulatory set-point. This cascade leads directly to the physiological outcome of antipyresis (fever reduction).

Modulation of Neural Signaling Pathways

Complementary effects emerge as the active compound is metabolized into N-arachidonoylphenolamine (AM404). This metabolite engages neural receptors, including Cannabinoid Receptor 1 (CB1) and the Transient Receptor Potential Vanilloid 1 (TRPV1) channel. By modulating the activity of the brain's descending inhibitory systems and nociceptive pathways, this secondary mechanism contributes to the overall physiological state of analgesia (decreased pain signaling).

Dosage and Administration Information

How to Use Pamol Flash

The usage of Pamol Flash is described in prescribing information detailing the proper administration technique, approved dosing, and schedule for its active ingredient, paracetamol. As an Orally Disintegrating Tablet (ODT), the administration route is oral, and the specific method requires the tablet to be placed on the tongue and allowed to dissolve, or to be chewed before swallowing. This specialized delivery system makes water unnecessary for intake.


Official Dosing and Frequency

Administration follows dosage and frequency patterns to maintain therapeutic effect while adhering to safety limits. For adults and adolescents 12 years and older, the typical single dose ranges from 500 mg to 1000 mg (1 g) of paracetamol. Doses must be separated by a required minimum interval of 4 hours.

Usage Parameter Guideline
Maximum Single Dose 1000 mg
Maximum Daily Dose Generally up to 4000 mg (4 g) in 24 hours. Some guidance mandates 3000 mg (3 g).
Administration Timing With or without food; empty stomach may accelerate onset.

Use Duration and Specific Adjustments

Pamol Flash is intended for short-term use only. Labeling specifies that the medication should not be used continuously for fever for more than 3 days or for pain for more than 5 days without medical evaluation. The product must not be consumed concurrently with any other paracetamol-containing medicine.

Population-Specific Rules: Dosing requires modification for individuals with compromised organ function. For patients with renal impairment, the interval between 500 mg doses must be prolonged, often to 6 or 8 hours. The maximum daily dose is typically restricted for patients with hepatic impairment.

Recent Clinical Evidence

Pamol Flash: Recent Clinical Evidence

Evidence for Use in Acute Mild-to-Moderate Pain

The research for this medicine involves numerous short-term Randomized Controlled Trials (RCTs) and Systematic Reviews. These studies primarily examined outcomes related to physical discomfort in contexts involving fluctuating or unstable symptoms. Researchers monitored patient-reported experiences of pain intensity in controlled models. Studies report the measured status of symptoms over short intervals (typically 4 to 6 hours), documenting patterns related to measured changes when compared to placebo. However, the evidence is focused on episodic changes, and the results apply primarily to the specific populations and conditions studied.

Evidence for Use in Fever Reduction (Antipyresis)

Research exploring temporary physiological imbalance includes RCTs and Systematic Reviews that have examined the association between administration and core body temperature. Studies monitored outcomes linked to physiological strain, such as changes in core body temperature (fever response) and the time required to reach a specific temperature threshold. Studies report the measured status of symptoms in the observed populations, documenting changes in body temperature following administration, which contributes to the evidence landscape for conditions involving fluctuating or unstable symptoms.

Research on the Fast-Dissolving (Flash) Format

Specialized Pharmacokinetic (PK) studies and Comparative single-dose trials were conducted to evaluate the delivery system. These studies explored the differences in the speed of drug absorption between the fast-dissolving format and standard tablets. Research reported data patterns related to the time needed to reach peak concentration and compared these measurements. This research provides context regarding short-term changes observed during the absorption phase.

Long-Term Studies and Follow-up

The existing research landscape is focused on short-term or episodic symptom patterns. Most efficacy trials feature follow-up durations that were limited, and there is limited information for long-term outcomes associated with repeated daily use.

Evidence in Specific Population Groups

The research base includes studies that have monitored outcomes in specific groups, particularly the pediatric populations for fever reduction. Data for certain groups, such as older adults or those with multiple pre-existing conditions, remain insufficient, as these individuals are often excluded from primary clinical trials.

Research Gaps and Areas of Uncertainty

The certainty remains low regarding the overall clinical relevance of some measured changes in certain settings. Furthermore, there is a lack of measured effect documented in the research for certain specific pain conditions, such as acute low back pain. Research highlights what is known—and what is still uncertain—about this medicine’s role.

Key Studies & References

  1. Acetaminophen - StatPearls - NCBI Bookshelf
  2. The efficacy and safety of paracetamol for pain relief: an overview of systematic reviews

Frequently Asked Questions (FAQ)

Common questions about Pamol Flash (FAQ)


Q: Is Pamol Flash the same thing as Tylenol or Panadol in other countries?

The active ingredient in Pamol Flash is paracetamol, which is known as acetaminophen in the United States. This core ingredient is found in many popular analgesic brands globally, including Tylenol and Panadol. Regulatory information confirms that while brand names vary, the pharmacological substance remains the same.


Q: Does Pamol Flash start working faster than standard pain relievers?

Official information indicates that the therapeutic effect typically begins about 30 minutes to one hour after a dose is taken. The formulation is an Orally Disintegrating Tablet (ODT) designed to dissolve quickly on the tongue, which may support an accelerated onset compared to traditional oral tablets.


Q: How long can I expect Pamol Flash's effect to last?

According to official product information, the pain-relieving or fever-reducing effect of the active ingredient typically lasts for about four to six hours. Regulatory guidance specifies that a minimum interval must be maintained between doses to ensure safe use.


Q: Are there any common side effects people mention about Pamol Flash?

When used according to official dosage guidelines, side effects are listed as rare in regulatory documents. These documents include warnings about rare adverse effects, such as serious allergic reactions and serious skin reactions.


Q: Can Pamol Flash cause drowsiness or make you tired?

Official information indicates that the active ingredient, paracetamol, is not a sedative and does not generally cause drowsiness or fatigue. Official warnings caution that drowsiness can be intensified if this medicine is consumed with alcohol or other medications that are known to cause sedation.


Q: Is it safe to take Pamol Flash if I'm taking blood pressure medication?

The active ingredient is generally considered compatible with blood pressure medications. However, official warnings note that prolonged daily use may be associated with cardiovascular adverse effects. Consultation with a healthcare professional is advised regarding prolonged use.


Q: What kind of interactions should I be aware of when using Pamol Flash?

Official documentation lists known interactions with certain medicines, including some used for blood thinning, nausea, epilepsy, and tuberculosis. Official guidance states that this product must not be taken concurrently with any other medicine containing paracetamol.


Q: Can people with stomach issues like ulcers use Pamol Flash?

Official product information notes that the active ingredient has a favorable gastrointestinal safety profile, meaning the risk of stomach irritation or ulcers is considered low. Nonetheless, caution is still advised, and professional advice should be sought.


Q: Is there a concern about liver safety with Pamol Flash?

Regulatory documents advise caution when this medicine is administered to patients with severe hepatic impairment, or existing liver problems. Exceeding the recommended dosage carries a specific risk of serious, delayed liver damage.


Q: Is Pamol Flash suitable for older adults?

Dosing guidelines typically include older adults within the standard adult dose range. Consultation with a healthcare professional is recommended prior to use, especially if existing organ impairment is present, as dose modification may be necessary.


Q: Is Pamol Flash considered safe to use during pregnancy according to official sources?

Official guidance states that this medicine is commonly taken during pregnancy and is often considered a first choice for pain relief. Official sources indicate that it should be used only as directed, at the lowest effective dose, and for the shortest possible duration.


Q: What does official research say about how quickly Pamol Flash works?

Official guidance indicates that the medicine may begin to ease pain and lower fever within 30 minutes to an hour of taking a dose. This speed of action is attributed to the fast dissolution and absorption characteristics of the formulation.


Q: Why do some people say Pamol Flash is good for migraines?

Regulatory documents specifically list the relief of pain associated with migraine headache as an approved indication for the active ingredient contained in Pamol Flash.


Q: Is Pamol Flash available over the counter?

The active ingredient in this medicine is commonly available without a prescription (over the counter) in many forms. However, some specific dosage strengths, combination products, or pack sizes may be classified as prescription-only medicine in certain jurisdictions.


Q: Can Pamol Flash be taken for muscle aches and body pain?

Official labeling lists the relief of pain, including pain associated with muscular aches and strains, as an approved use for the active ingredient.


Q: Does Pamol Flash interact with alcohol?

Official warnings advise caution regarding alcohol consumption. Regular or excessive alcohol use increases the risk of liver damage when taking this medication. Consultation with a healthcare professional is advised if the maximum weekly recommended alcohol intake is regularly exceeded.


Q: Is Pamol Flash described as non-addictive in official documents?

Official documents classify the active ingredient, paracetamol, as an analgesic (pain reliever) and antipyretic (fever reducer). It is not classified as a narcotic or scheduled substance.


Q: Are there specific food types that interact with Pamol Flash?

Regulatory information indicates that there are no specific food types that are known to interact with the active ingredient. The medicine may be taken with or without food.


Q: Why is Pamol Flash sold in different strengths?

The medicine is available in different strengths to allow for flexibility in dosing. This is done to address varying levels of pain or fever and to ensure appropriate administration for different authorized populations.


Q: What is the classification of Pamol Flash (e.g., NSAID, analgesic)?

The medicine's active ingredient is classified by regulatory bodies as an analgesic (pain reliever) and antipyretic (fever reducer). It is important to note that it is not classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID).


Q: What are the general warnings for using Pamol Flash?

General warnings from official documentation emphasize the instruction not to exceed the maximum recommended daily dose. Regulatory guidance also specifies that it must not be taken concurrently with any other product containing paracetamol.


Q: Is Pamol Flash listed as having interactions with other common pain relievers?

Regulatory information specifies that it must not be taken concurrently with any other paracetamol-containing medicine. Official guides indicate that the active ingredient may be taken with certain non-paracetamol pain relievers, such as ibuprofen, if necessary.


Q: What happens if I miss a scheduled time for Pamol Flash?

If a scheduled dose is missed, regulatory instructions indicate that the next dose should only be taken when needed. The minimum time interval specified in the dosing schedule (such as 4 hours) is required before the next dose is administered.


Q: Why is the 'Flash' formulation sometimes preferred by users?

The 'Flash' formulation is an Orally Disintegrating Tablet (ODT) that is designed to dissolve directly on the tongue or be chewed before swallowing. This administration method is often preferred because it makes taking the medicine with water unnecessary.


Q: Can people with high blood pressure use Pamol Flash?

The active ingredient is generally considered compatible with high blood pressure. However, official warnings note that prolonged daily use may be associated with cardiovascular adverse effects. Consultation with a healthcare professional is advised regarding prolonged use.


Q: Can I take Pamol Flash before driving or operating machinery?

Official information indicates that the active ingredient is not generally expected to cause drowsiness or impair the ability to drive or operate machinery. However, regulatory guidance advises caution when this medicine is combined with other substances that are known to cause sedation.


Q: Is Pamol Flash considered a prescription-only medicine in some regions?

While the medicine is widely available over the counter, certain dosages, combinations, or pack sizes may be classified as prescription-only medicine in some regions. This classification is determined by local regulatory authorities.


Q: Are there special warnings for people with heart problems using Pamol Flash?

Official warnings note that prolonged daily use may be associated with cardiovascular adverse effects. Consultation with a healthcare professional is recommended for individuals with existing heart conditions, especially when considering long-term use.


Q: What is the expected window of time for peak effect of Pamol Flash?

Regulatory documents, such as the Summary of Product Characteristics, contain information regarding the time taken to reach peak plasma concentration after administration. This value represents the expected window of time for the peak therapeutic effect.


Q: Does Pamol Flash have a black box warning in regulatory documents?

Single-ingredient products containing the active substance in Pamol Flash do not carry a U.S. FDA Black Box Warning. The most serious warnings relate to the potential for severe, delayed liver damage and rare but serious skin reactions.


Q: Can Pamol Flash be used to relieve menstrual pain?

Regulatory documents list the relief of pain, including period pain (menstrual pain), as an approved indication for the active ingredient.


Q: Does Pamol Flash have a coating that affects its speed of action?

Pamol Flash is an Orally Disintegrating Tablet (ODT) which is formulated to dissolve directly on the tongue. This rapid dissolution is an inherent part of the product's design, rather than being affected by a coating, which is common in traditional tablets.


Q: What conditions make someone ineligible to use Pamol Flash, according to official information?

Official warnings advise against use if a person has a known allergy (hypersensitivity) to the active substance or any other ingredients. Individuals with severe liver or kidney problems are advised to seek professional consultation.


Q: Is Pamol Flash generally well-tolerated by most people?

When used at the recommended dosage, official sources indicate that the active ingredient is generally considered to be well-tolerated by most people. Side effects are generally reported as rare in official documentation.


Q: What happens if Pamol Flash is taken close to another dose of a different pain medication?

Regulatory instructions strictly prohibit taking this medicine concurrently with any other product containing paracetamol. If the other pain reliever does not contain paracetamol, official guides advise checking the label for specific active ingredients and observing the minimum dose interval specified on the label.


Q: Why is Pamol Flash sometimes available in chewable or liquid forms?

The active ingredient paracetamol is commonly available in various forms, including liquids and other soluble preparations. These alternative forms are often intended for use by children or others who may have difficulty swallowing tablets.


Q: Can I take Pamol Flash if I am breastfeeding, based on official safety data?

Official guidance states that this medicine can be taken at recommended doses while breastfeeding. It is often considered a first-choice painkiller during this period because it passes into breast milk in very small amounts.


Q: Are there any interactions between Pamol Flash and herbal supplements?

Official guidance requires disclosing to a healthcare professional all medicines, vitamins, and herbal or dietary supplements being taken. This is because some herbal products, such as St. John's Wort, may affect the safety profile of the medicine.


Q: What are the official indications for Pamol Flash?

Official documents list the uses of the active ingredient for the temporary relief of mild to moderate pain (such as headache, toothache, muscular aches, and period pain) and to reduce fever.

How should Pamol Flash be stored and disposed of?

How to Store and Dispose of Pamol Flash

Official regulatory guidelines strictly define the conditions necessary to store and dispose of this medicine.

Storage Requirements

Condition Requirement (Official Statement)
Temperature Store below 30 C or at controlled room temperature.
Protection The tablets must be protected from moisture and stored in the original packaging to protect from light.
Packaging Keep the medication in the container it came in, with the closure tightly closed.
Child Safety Store strictly out of the sight and reach of children.

Disposal Instructions

Unused or expired Pamol Flash must be disposed of in accordance with local requirements.

Medication should generally not be flushed down the toilet or disposed of in household waste. The recommended procedure is to utilize a local drug take-back program to ensure safe environmental handling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pamol Flash found in:

A-Z Index: